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Supplemental figure 1
Supplemental Figure 1: IFNγ production is reduced in NK and CD4+ T cells from T-bet deficient mice,
Related to Figure 1.
Representative plots and percentage of IFNγ-producing A) NK cells and B) T cells in the spleen of WT
and T-bet−/−mice. NK cells are defined as CD4-NK1.1+NKp46+ cells. T cells are gated as CD4 + cells.
Data are expressed as mean ± SEM and are representative of at least three independent experiments
(n=3). *p < 0.05.
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SUPPLEMENTAL FIGURES
Supplemental figure 2
Supplemental Figure 2: Characterisation of surface markers expressed by ILC2s, Related to Figure 1.
Representative plot and histograms showing: A) the expression of surface markers in IL-5 and IL-13
producing ILCs in comparison with IL-5- IL-13- ILCs isolated from the cLP of WT mice and stimulated
with PMA (50 ng/ml) and ionomycin (1 μg/ml) and ionomycin for 4h prior to intracellular cytokine and
surface markers staining; B) GATA-3 expression in CD25+ c-Kit+ ILCs from the spleen of T-bet-/-mice.
ILCs are defined as CD45+ Lin- IL-7Rα+ cells.
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Supplemental figure 3
Supplemental Figure 3: Lack of IFNγ is not linked to an expansion of ILC2s, Related to Figure 1.
A-B) Flow cytometry analysis of the different ILC populations in the cLP of WT and IFNγ-/- mice
showing: A) Representative plots showing the ILC population within CD45+ cells and absolute cell
numbers of ILCs; B) Representative plots and absolute cell numbers of KLRG1+ICOS+NKp46- ILCs; C)
Representative plots and absolute cell numbers of NKp46+ and NKp46- RORγt+ ILCs. ILCs are defined
as CD45+Lin-IL-7Rα+ cells; ILC2s are defined as CD45+Lin-IL-7Rα+ICOS+KLRG1+ cells. Data are
expressed as mean ± SEM (n=3). ns: non-significant.
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Supplemental figure 4
Supplemental Figure 4: ST2 and IL-17RB expression in T-bet+/+ and T-bet−/− ILCs, Related to Figure 1.
A) Percentage of IL-13+ ILCs and B) representative flow cytometry plots showing expression of ST2 and
IL-17RB in IL-13+ ILCs from the cLP of T-bet+/+ and T-bet−/−mice at baseline (-, unstimulated) and after
4h of stimulation with IL-25 (50ng/ml), IL-33 (50ng/ml), or PMA (50 ng/ml) and ionomycin (1 μg/ml)
(P/I). ILCs were defined and FACS-sorted CD45+Lin-IL-7Rα+ cells.
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Supplemental figure 5
Supplemental Figure 5: STAT-3 and STAT-4 activation in ILCs in response to IL-7 is not altered in the
absence of T-bet, Related to Figure 3.
Representative flow cytometry analysis of the phosphorylation of STAT-3 and STAT-4 in ILCs from the
cLP of WT and T-bet−/−mice after stimulation with IL-7 (50ng/ml, 60 minutes). Data are expressed as
mean ± SEM (n=3). ILCs were defined as CD45+Lin-IL-7Rα+ cells.
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Supplemental figure 6
Supplemental Figure 6: IL-2Rα expression and signalling is not altered in ILCs from T-bet deficient
mice, Related to Figure 3.
A) Representative flow cytometry analysis of the phosphorylation of STAT5 in ILCs from the cLP of
WT and T-bet−/−mice after stimulation with IL-2 (50ng/ml, 60 minutes). Numbers indicate
percentages.
B) Density of expression of IL-2Rα (CD25) in ILC2s from the cLP of WT and T-bet−/−mice expressed
as mean fluorescent intensity (MFI). ILC2s were defined as CD45+Lin-IL-7Rα+KLRG1+ICOS+ cells.
Data are expressed as mean ± SEM and are representative of at least three independent experiments
(n=3). ns= non significant.
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Supplemental figure 7
Supplemental Figure 7: Representative histogram showing intracellular staining for T-bet in NKp46+ and
NKp46- ILCs from WT mice and in ILCs from T-bet−/−mice. ILCs are defined as CD45+ Lin- IL-7Rα+ cells.
Related to Figure 5.
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Supplemental figure 8
Supplemental Figure 8: T-bet Expression in T cells from the T-betΔNCR+ILC mouse is Not Altered, Related to
Figure 5.
A) Representative histogram showing intracellular staining for T-bet in NKp46+ and NKp46- CD3+ cells
from WT, T-bet−/− and T-betΔNCR+ILC mice. B) Real-time PCR measuring the transcripts of Tbx21, Ifng and
Gata3 in Th1 and Th2 in vitro differentiated cells from the spleen of WT, T-bet−/− and T-betΔNCR+ILC mice
(n=3). Fold change expressed as mean ± SEM vs. T-betΔNCR+ILC.
Data are expressed as mean ± SEM and are representative of at least three independent experiments. ns:
non-significant; ***p<0.001.
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Supplemental Figure 9: Maturation and IFNγ Production by NK Cells from T-betΔNCR+ILC mice are Not
Affected by the Absence of T-bet, Related to Figure 5.
Representative flow cytometry plots showing the percentage of NK cells in the spleen of WT, T-betΔNCR+ILC
and T-bet−/−mice. Percentage and absolute cell numbers (n=3) of NK cells in the spleen of the different
mouse strains. B) Representative flow cytometry plots showing the percentages of CD11bhiCD27hi NK cells
in the spleen of WT, T-betΔNCR+ILC and T-bet−/− mice. C) Representative flow cytometry plots showing
intracellular staining for IFNγ in unstimulated splenic NK cells from WT and T-betΔNCR+ILCmice and after
stimulation with IL-12 and IL-18 for 5 and 20 hours.
Data are expressed as mean ± SEM and are representative of at least three independent experiments. ns:
non-significant; *p < 0.05; **p< 0.01.
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Supplemental figure 10
Supplemental Figure 10: Ncr1-iCreTg and T-betfl/fl mice Develop DSS-Colitis Comparable to WT mice,
Related to Figure 7.
Panels 1A-D show DSS-colitis phenotype in WT and T-betfl/fl mice. Panels 2A-D show DSS-colitis
phenotype in WT and Ncr1-iCreTg mice. A) Weight increment (%) and B) Disease activity index (DAI)
values over the 10-day experimental period; C) Colon weight/length ratio and D) Spleen weight. NC
represent Non-colitic mice, DSS represent DSS-treated mice. DAI values were calculated based on the
criteria proposed previously (Cooper et al., 1993). Data are expressed as Mean +/- SEM (n=4).
